Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.)

FDA inspection history in Vadodara, India, 2024

1
Form 483

Every document, by year

  • Form 483

2024: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2024One Form 483, at Vadodara, India.

Cited most

Across all Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.) observations on file

  • 21 CFR 201.122
    Drugs for processing, repacking, or manufacturing
    1

The complete Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.) file.

All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.

$99

The documents one by one, while the file is prepared

See the documents

Sites

Documents

1 on file, newest first
DateDocumentPrice
2024-01-12483 Form 483$99

Investigators on these documents

Kham Phommachanh (1)

FEI number 3007836955 · most recent document Jan 12, 2024

About Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.)

How many FDA Form 483s has Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.) received?

FDA Intel has 1 Form 483 on file for Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.); the most recent is dated Jan 12, 2024.

When was Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.) last inspected by FDA?

The most recent FDA inspection document on file for Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.) is a Form 483 dated Jan 12, 2024, for the site in Vadodara, India.

What did FDA cite at Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.)?

The regulations cited most in the observations on file for Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.) are 21 CFR 201.122 (Drugs for processing, repacking, or manufacturing), 1 time.